跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Nordette
Approved
STANDARD
Nordette
Pfizer, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
200bf0c478a1bfa2
Company
Pfizer, Inc.
Type
Standard
Approval Details
Approval Id
200bf0c478a1bfa2
Drug Approval Philippines Name
Nordette
Product Name
Nordette
Registration Number
DR-XY23241
Brand Name
Nordette
Generic Name
Levonorgestrel + Ethinylestradiol
Dosage Form
Tablet
Dosage Strength
150 mcg/30 mcg
Manufacturer
Pfizer, Inc.
Company Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Issuance Date
15 September 2022
Expiry Date
16 November 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
200bf0c478a1bfa2
Type
Standard
Back to Philippines FDA Approvals
Nordette - Philippines FDA Drug Approval Details